Yiwei Zhang

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 185 citations

Life Sciences, Immunology, Neurology +11

Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning

Akbar K. Waljee, Rachel Lipson, Wyndy L. Wiitala et al. · Inflammatory Bowel Diseases · 2017 · 114 citations · Full text

Computing, Internal Medicine, Clinical Decision Support +16

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53

Qi Zhang, Shelya X. Zeng, Yu Zhang et al. · EMBO Molecular Medicine · 2012 · 108 citations · Full text

Medicine, Molecular Biology, Oncology +15

Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator

Xiang Zhou, Qian Hao, Peng Liao et al. · eLife · 2016 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

Helen Kotanides, Yiwen Li, Maria Malabunga et al. · Cancer Immunology Research · 2020 · 68 citations

Life Sciences, Immunology, Oncology +17